Struggling GSK Recruits Cancer Drug Guru Hal Barron As Its New R&D Chief

November 09, 2017 | GlaxoSmithKline has recruited Hal Barron, one of the world's top cancer drug investigators, to take the helm of its troubled pharma R&D group, offering a fresh sign that the pharma giant is jumping back in a big way into oncology. ENDPOINTS